FTSE All-Share
|
5 330,64
|
5,42
|
0,10 %
|
Analysen zu FTSE All-Share-Werten
| 04.06.24 | BAT Buy | Jefferies & Company Inc. | |
| 04.06.24 | BAT Neutral | JP Morgan Chase & Co. | |
| 04.06.24 | GSK Buy | UBS AG | |
| 04.06.24 | BAT Neutral | UBS AG | |
| 04.06.24 | AstraZeneca Sell | UBS AG | |
| 04.06.24 | BAT Sector Perform | RBC Capital Markets | |
| 04.06.24 | GSK Buy | Deutsche Bank AG | |
| 04.06.24 | Diageo Sell | UBS AG | |
| 03.06.24 | GSK Buy | Jefferies & Company Inc. | |
| 03.06.24 | Rio Tinto Overweight | JP Morgan Chase & Co. | |
| 03.06.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 03.06.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 03.06.24 | GSK Buy | Deutsche Bank AG | |
| 03.06.24 | GSK Neutral | Goldman Sachs Group Inc. | |
| 03.06.24 | National Grid Market-Perform | Bernstein Research | |
| 31.05.24 | National Grid Outperform | RBC Capital Markets | |
| 31.05.24 | National Grid Buy | Jefferies & Company Inc. | |
| 31.05.24 | HSBC Holdings Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 30.05.24 | Unilever Sector Perform | RBC Capital Markets | |
| 30.05.24 | GSK Neutral | Goldman Sachs Group Inc. | |
| 30.05.24 | BAT Buy | Jefferies & Company Inc. | |
| 30.05.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 29.05.24 | National Grid Buy | UBS AG | |
| 28.05.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 28.05.24 | National Grid Outperform | RBC Capital Markets | |
| 24.05.24 | National Grid Market-Perform | Bernstein Research | |
| 24.05.24 | National Grid Neutral | Goldman Sachs Group Inc. | |
| 23.05.24 | National Grid Outperform | RBC Capital Markets | |
| 23.05.24 | National Grid Neutral | Goldman Sachs Group Inc. | |
| 23.05.24 | National Grid Buy | UBS AG | |
| 23.05.24 | National Grid Outperform | RBC Capital Markets | |
| 23.05.24 | National Grid Overweight | JP Morgan Chase & Co. | |
| 23.05.24 | Vodafone Group Buy | Goldman Sachs Group Inc. | |
| 23.05.24 | BAT Neutral | UBS AG | |
| 23.05.24 | Unilever Overweight | JP Morgan Chase & Co. | |
| 22.05.24 | AstraZeneca Hold | Deutsche Bank AG | |
| 22.05.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 21.05.24 | BAT Buy | Deutsche Bank AG | |
| 21.05.24 | BP Buy | UBS AG | |
| 21.05.24 | AstraZeneca Sell | UBS AG |
HOT STOCKS DER LETZTEN 3 TAGE
| Vodafone Group | 4 |
| AstraZeneca | 4 |
| London Stock Exchange | 3 |
| Diageo | 3 |
| BAT | 1 |
| Unilever | 1 |
Analysen zu Aktien folgender Indizes
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.